symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
GSTC,0.00215,1.275146,3976802,2010011,0,0.0016-0.0241,-0.0005,GlobeStar Therapeutics Corporation,USD,0001502152,,37960P104,Other OTC,PNK,Biotechnology,https://www.globestarthera.com,"GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.",Mr. James C. Katzaroff,Healthcare,US,,206 451 1970,719 Jadewin Avenue,Richland,WA,99352,,0,https://financialmodelingprep.com/image-stock/GSTC.png,2011-09-26,False,False,True,False,False
